SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Toshihiko Ishimitsu, Hirofumi Fukuda, Masako Uchida, Kazushi Ishibashi, Fusako Sato, Kazuhiko Nukui, Munehiko Nagao, The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; Safety and efficacy in patients with hypertension) study, Clinical and Experimental Hypertension, 2015, 1

    CrossRef

  2. 2
    A. Maione, S. D. Navaneethan, G. Graziano, R. Mitchell, D. Johnson, J. F. E. Mann, P. Gao, J. C. Craig, G. Tognoni, V. Perkovic, A. Nicolucci, S. De Cosmo, A. Sasso, O. Lamacchia, M. Cignarelli, V. Maria Manfreda, G. Gentile, G. F. M. Strippoli, Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials, Nephrology Dialysis Transplantation, 2011, 26, 9, 2827

    CrossRef

  3. 3
    Tomasz Stompór, Maria Napora, Artur Olszewski, Renoprotective effects of benazepril: current perspective, Expert Review of Cardiovascular Therapy, 2011, 9, 6, 663

    CrossRef

  4. 4
    Vivencio Barrios, Carlos Escobar, Antihypertensive and organ-protective effects of benazepril, Expert Review of Cardiovascular Therapy, 2010, 8, 12, 1653

    CrossRef